Noninvasive Neuromodulation in Parkinson’s Disease: Insights from Animal Models

9Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

The mainstay treatments for Parkinson’s Disease (PD) have been limited to pharmacotherapy and deep brain stimulation. While these interventions are helpful, a new wave of research is investigating noninvasive neuromodulation methods as potential treatments. Some promising avenues have included transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), electroconvulsive therapy (ECT), and focused ultrasound (FUS). While these methods are being tested in PD patients, investigations in animal models of PD have sought to elucidate their therapeutic mechanisms. In this rapid review, we assess the available animal literature on these noninvasive techniques and discuss the possible mechanisms mediating their therapeutic effects based on these findings.

Cite

CITATION STYLE

APA

Muksuris, K., Scarisbrick, D. M., Mahoney, J. J., & Cherkasova, M. V. (2023, September 1). Noninvasive Neuromodulation in Parkinson’s Disease: Insights from Animal Models. Journal of Clinical Medicine. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/jcm12175448

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free